(Q45300743)

11 December 2017

title

Letter: G.A.B.A. and Huntington's chorea (English)

1 reference

11 December 2017

0 references

A Barbeau

1

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 December 1973

1 reference

11 December 2017

number of pages

2

1 reference

inferred from page(s)

published in

The Lancet

1 reference

11 December 2017

volume

2

1 reference

11 December 2017

issue

7844

1 reference

11 December 2017

page(s)

1499-1500

1 reference

Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992765-7

7 January 2021

Reduced glutamic-acid-decarboxylase activity of post-mortem brain in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992765-7

7 January 2021

Neurotransmitter synthetic enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992765-7

7 January 2021

Glutamic acid decarboxylase in Parkinson's disease and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992765-7

7 January 2021

Effects of globus pallidus lesions and Parkinson's disease on brain glutamic acid decarboxylase.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992765-7

7 January 2021

L-Glutamic Acid Decarboxylase in Parkinson's Disease: Effect of L-Dopa Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992765-7

7 January 2021

Central cholinergic-anticholinergic antagonism in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992765-7

7 January 2021

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992765-7

7 January 2021

Antagonism by taurine of cobalt induced epilepsy in cat and mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992765-7

7 January 2021

Development of an anticonvulsant agent based on its effect on -aminobutyric acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992765-7

7 January 2021

Baclofen and lithium in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992765-7

7 January 2021

Lithium therapy in Huntington's chorea and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992765-7

7 January 2021

Lithium and levodopa in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2992765-7

7 January 2021

10.1016/S0140-6736(73)92765-7

Identifiers

DOI

1 reference

11 December 2017

1 reference